Indicators for blood glucose control in diabetics with end -stage chronic renal disease: GHb vs. glycated albumin (GA)

Journal of Medical Investigation

Volumn 53, Issue 3-4, 2006, Pages 223-228

  Chujo, Keiko ^a   Shima, Kenji ^a   Tada, Hiroaki ^a   Oohashi, Teruyo ^a   Minakuchi, Jun ^a   Kawashima, Syu ^a  

^a Kawashima Hospital   (Japan)

Author keywords

Daily profile of blood glucose; Glycated albumin; Glycohemoglobin; Hemodialysis; Life span of erythrocyte

Indexed keywords

GLYCOSYLATED ALBUMIN; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DIABETES MELLITUS; DIALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; DIABETIC NEPHROPATHIES; ERYTHROCYTES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; RENAL DIALYSIS; SERUM ALBUMIN;

EID: 33750334070     PISSN: 13431420     EISSN: None     Source Type: Journal    
DOI: 10.2152/jmi.53.223     Document Type: Article

References (12)

1. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin -dependent diabetes mellitus. N Engl J Med 329: 977-986, 1993
2. UK Prospective Diabetes Group: Intensive blood-glucose control with sulphonylurea or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853, 1998
3. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin dependent diabetes mellitus-a randomized prospective 6-year study-. Diab Res Clin Pract 28: 103-117, 1995
4. Dandona P, Freedman D, Moorhead JF: Glycosylated haemoglobin in chronic renal failure. Br Med J 1: 1183-1184, 1979
5. Boer MJ, Miedema K, Casparie AF: Glycosylated haemoglobin in renal failure. Diabetologia 18: 437-440, 1980
6. Eschbach JW Jr, Funk D, Adamson J, Kuhn I, Scribner BH, Finch CA: Erythropoiesis in patients with renal failure undergoing chronic dialysis. N Engl J Med 276: 653-658, 1967
7. Nakao T, Matsumoto H, Okada T, Han M, Hidaka H, Yoshino M, Shino T, Yamada C, Nagaoka Y: Influence of erythropoietin treatment on hemoglobinAlc levels in patients with chronic renal failure on hemodialysis. Intern Med 37: 826-830, 1998
8. Shima K, Ito N, Abe F, Hirota M, Yano M, Yamamoto Y, Uchida T, Noguchi K: High-performance liquid chromatographic assay of serum glycated albumin. Diabetologia 31:627-631, 1988
9. Jiao Y, Okumiya T, Tsubosaki E, Matsumura H, Park K, Sugimoto K, Kageoka T, Sasaki M: An enzymatic assay for erythrocyte creatine as an index of the erythrocyte life time. Clin Biochem 31: 59-65, 1998
10. Fluckiger R, Harmon W, Meier W, Loo S, Gabby H: Hemoglobin carbamylation in uremia. N Engl J Med 304: 823-827, 1981
11. Smith WG, Holder M, Benton M, Brown CB: Glycosylated and carbamylated haemoglobin in uremia. Nephrol Dial Transplant 4: 96-100, 1989
12. Takemoto Y, Okumiya T, Tsuchida K, Nakatani T, Yamamoto K: Erythrocyte creatine as an index of the erythrocyte life span and erythropoiesis. Nephron 86: 513-514, 2000